Back to WELLS FARGO & COMPANY/MN WELLS FARGO & COMPANY/MN

BTAIBTAI
6 quarters

Position history for WELLS FARGO & COMPANY/MNWELLS FARGO & COMPANY/MN's holdings in BIOXCEL THERAPEUTICS INC

WELLS FARGO & COMPANY/MN holds 4,337 shares of BTAI (BIOXCEL THERAPEUTICS INC), worth $6,115 as of 2026-Q2. The position was increased (+0.4% shares).

Current Value

$6,115

Current Shares

4,337

Total Value Change

-$18,840

Total Shares Change

-7,956

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4,337
+0.4%
$6,1150.0%$1.41
11
2026-Q1
Decreased
4,319
-0.1%
$5,7870.0%$1.60
0
2025-Q4
Decreased
4,325
-73.5%
$6,9200.0%$1.53
0
2025-Q3
Decreased
16,316
-3.6%
$41,7690.0%$2.62
0
2025-Q2
Increased
16,919
+37.6%
$30,6230.0%$1.77
17
2025-Q1
New
12,293
-
$24,9550.0%$2.12
29

Other major holders of BTAI: MILLENNIUM MANAGEMENT LLC, OAKTREE CAPITAL MANAGEMENT LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used